A Mini-Review: Clinical Development and Potential of Aptamers for Thrombotic Events Treatment and Monitoring

被引:23
作者
Ponce, Alex T. [1 ]
Hong, Ka Lok [1 ]
机构
[1] Wilkes Univ, Dept Pharmaceut Sci, Nesbitt Sch Pharm, 84 W South St, Wilkes Barre, PA 18766 USA
关键词
thrombotic event; aptamer; DNA; RNA; SELEX; molecular recognition element (MRE); monitoring; treatment; WILLEBRAND-FACTOR A1-DOMAIN; DIRECT ORAL ANTICOAGULANTS; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; INHIBITS THROMBIN; HIGH-AFFINITY; GENERATION; SELECTION; LIGANDS; COAGULATION;
D O I
10.3390/biomedicines7030055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The unique opportunity for aptamer uses in thrombotic events has sparked a considerable amount of research in the area. The short half-lives of unmodified aptamers in vivo remain one of the major challenges in therapeutic aptamers. Much of the incremental successful therapeutic aptamer stories were due to modifications in the aptamer bases. This mini-review briefly summarizes the successes and challenges in the clinical development of aptamers for thrombotic events, and highlights some of the most recent developments in using aptamers for anticoagulation monitoring.
引用
收藏
页数:15
相关论文
共 62 条
[1]   In Vitro Selection of Specific DNA Aptamers Against the Anti-Coagulant Dabigatran Etexilate [J].
Aljohani, Maher M. ;
Chinnappan, Raja ;
Eissa, Shimaa ;
Alsager, Omar A. ;
Weber, Karina ;
Cialla-May, Dana ;
Popp, Juergen ;
Zourob, Mohammed .
SCIENTIFIC REPORTS, 2018, 8
[2]   Investigating the properties of TBA variants with twin thrombin binding domains [J].
Amato, Teresa ;
Virgilio, Antonella ;
Pirone, Luciano ;
Vellecco, Valentina ;
Bucci, Mariarosaria ;
Pedone, Emilia ;
Esposito, Veronica ;
Galeone, Aldo .
SCIENTIFIC REPORTS, 2019, 9 (1)
[3]   Assessment of the effect of direct oral anticoagulants dabigatran, rivaroxaban, and apixaban in healthy male volunteers using a thrombin generation assay [J].
Artang, Ramin ;
Anderson, Maren ;
Riley, Paul ;
Nielsen, Jorn D. .
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2017, 1 (02) :194-201
[4]   Thrombin Binding Aptamer, More than a Simple Aptamer: Chemically Modified Derivatives and Biomedical Applications [J].
Avino, Anna ;
Fabrega, Carme ;
Tintore, Maria ;
Eritja, Ramon .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (14) :2036-2047
[5]   SELECTION OF SINGLE-STRANDED-DNA MOLECULES THAT BIND AND INHIBIT HUMAN THROMBIN [J].
BOCK, LC ;
GRIFFIN, LC ;
LATHAM, JA ;
VERMAAS, EH ;
TOOLE, JJ .
NATURE, 1992, 355 (6360) :564-566
[6]   A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity [J].
Bompiani, K. M. ;
Monroe, D. M. ;
Church, F. C. ;
Sullenger, B. A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (05) :870-880
[7]   An Anticoagulant RNA Aptamer That Inhibits Proteinase-Cofactor Interactions within Prothrombinase [J].
Buddai, Sai K. ;
Layzer, Juliana M. ;
Lu, Genmin ;
Rusconi, Christopher P. ;
Sullenger, Bruce A. ;
Monroe, Dougald M. ;
Krishnaswamy, Sriram .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (08) :5212-5223
[8]   A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release [J].
Burrell, K. -A. Steen ;
Layzer, J. ;
Sullenger, B. A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (09) :1807-1817
[9]   Aptamer Cell-Based Selection: Overview and Advances [J].
Catuogno, Silvia ;
Esposito, Carla Lucia .
BIOMEDICINES, 2017, 5 (03)
[10]   General mechanisms of coagulation and targets of anticoagulants (Section I) Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease [J].
De Caterina, Raffaele ;
Husted, Steen ;
Wallentin, Lars ;
Andreotti, Felicita ;
Arnesen, Harald ;
Bachmann, Fedor ;
Baigent, Colin ;
Huber, Kurt ;
Jespersen, Jorgen ;
Kristensen, Steen Dalby ;
Lip, Gregory Y. H. ;
Morais, Joao ;
Rasmussen, Lars Hvilsted ;
Siegbahn, Agneta ;
Verheugt, Freek W. A. ;
Weitz, Jeffrey I. .
THROMBOSIS AND HAEMOSTASIS, 2013, 109 (04) :569-579